The Latest Cardiac and Vascular News
CALGARY, AB and SAN FRANCISCO, April 20, 2022 /PRNewswire/ — Thoma Bravo, a leading software investment firm, today announced the completion of its strategic growth investment in Circle Cardiovascular Imaging Inc. (“Circle CVI”), the global leader in cardiovascular imaging solutions. Circle CVI is the leading provider of AI-based cardiac imaging and reporting solutions, including […]
ARTARMON, Australia, April 20, 2022 /PRNewswire/ — Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced neural activation and sensing technologies designed to treat debilitating neurological disorders, today announced the appointment of Robert (Bob) Palmisano to its Board of […]
Sales growth of 13.8 percent; organic sales growth of 17.5 percent Global COVID-19 testing-related sales of $3.3 billion in the first quarter Excluding COVID-19 testing-related sales, first-quarter reported sales growth of 3.9 percent and organic sales growth of 7.7 percent GAAP diluted EPS growth of 37.0 percent; adjusted diluted EPS growth of […]
Company advances its next-generation thrombectomy device CAMPBELL, Calif., April 19, 2022 /PRNewswire/ — Akura Medical, Inc., a Shifamed portfolio company, announced today that seasoned medtech executive, Murali Srivathsa, has joined as President and CEO. With over two decades of industry experience, Murali brings a wealth of medical device and senior leadership expertise. He joins as […]
MORRISVILLE, N.C., April 18, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) today announced the closing of its previously announced underwritten public offering of 11,274,510 shares of its common stock, which includes full exercise of the underwriters’ over-allotment option to purchase 1,470,588 additional shares of common stock, at a […]
WESTMINSTER, Colo., April 18, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that its Board of Directors has established a Special Committee to evaluate strategic options for maximizing stockholder value. The Company believes […]
MONTREAL and CHARLOTTE, N.C., April 15, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Milestone’s Compensation Committee granted one new employee 65,000 incentive stock options at a per share exercise price of $6.85, the closing price of Milestone’s common stock on April […]
AUDUBON, Pa.–(BUSINESS WIRE)–AIROS® Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy products that treat lymphedema and venous disorders, today announced it has hired Adrien Grey MacKenzie, LMT, PTA, CLT-LANA and Kelly Sturm, DPT, CLT-LANA as clinical advisors. Ms. MacKenzie is a national board-certified health and wellness […]
MONMOUTH JUNCTION, N.J., April 14, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that it has registered a new subsidiary, CytoSorbents Medical UK Limited, with plans to establish a direct sales presence within the United Kingdom (UK) and Ireland. CytoSorbents previously sold […]
WASHINGTON, April 13, 2022 /PRNewswire/ — Anekwe E. Onwuanyi, MD, FACC, was installed as the 19th President of the Association of Black Cardiologists (ABC) during the Spring 2022 Membership Meeting. He is the first board-certified, advanced heart failure specialist to hold the position in ABC’s nearly 50-year history. Dr. Onwuanyi is Professor of Medicine […]
